Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Stem Cell Reports is Scopus-indexed (Q1, CiteScore 9.3), WoS SCIE, DOAJ. Published by Cell Press.
Checked against the index lists dated .
ISSN 2213-6711Verify ISSN ↗
Publisher: Cell Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 41 / 357 | 88th | Q1 |
| Developmental Biology | 10 / 78 | 87th | Q1 |
| Biochemistry | 64 / 448 | 85th | Q1 |
| Cell Biology | 65 / 289 | 77th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q1, CiteScore 9.3.
Stem Cell Reports is Q1 in Genetics (rank 41 of 357), Q1 in Developmental Biology (rank 10 of 78) and Q1 in Biochemistry (rank 64 of 448), by CiteScore 2025. It is ranked in 4 subject areas in all.
Stem Cell Reports is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.3, which places it in quartile Q1 at the 88th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.038, quartile Q1, with an H-index of 127.
The publisher lists an article processing charge of about US$4,190 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Stem Cell Reports is published by Cell Press. Its ISSN is 2213-6711.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Stem Cell Reports has an h-index of 150 and a 2-year mean of 4.88 citations per paper (OpenAlex). Its Scopus CiteScore is 9.3, quartile Q1. On 2-year citations it ranks #54 of 353 Scopus journals in Genetics.
Stem Cell Reports published 189 papers in 2025; its busiest recent year was 2017 with 317. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from United States (27.1%), China (17.4%) and Japan (11.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.